drugset / Trial / NCT03185182
Diagnostic Imaging for Clear Cell Renal Cell Carcinoma
NaSingle-groupOpen-labelDiagnostic
Summary
The main objective is to study whether imaging detection of the biomarker DAT can be used to detect kidney tumors identified by computer tomography (CT), which are pathologically assesses as being of the clear cell subtype.
Timeline
- Start
- 2017-07-14
- Primary completion
- 2018-09-12
- Completion
- 2018-09-12
Outcome
Outcome not reported
Stopped: “Due to "early stopping rule" as defined in the study protocol”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ioflupane 123I | Unknown | 185 mbq | Intravenous |